Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Amsterdam’s VectorY Therapeutics raises €74.5 million to tackle ALS and other neurodegenerative diseases - EU-Startups
VectorY Therapeutics is focused on developing innovative therapies for ALS and other neurodegenerative diseases. The company aims to address significant unmet medical needs in this challenging area of healthcare. The recent funding will support their research and development efforts.
Amsterdam’s VectorY Therapeutics raises €74.5 million to tackle ALS and other neurodegenerative diseases EU-Startups
| Nov 10, 2026 | Onodrim | $300.0M | Series A | Netherlands |
| Nov 06, 2026 | Logiqs | $32.7M | — | Netherlands |
| Oct 20, 2026 | Learned | $3.4M | Angel | Netherlands |
| Oct 08, 2026 | Innercrowd | $750K | — | Netherlands |
You just read who funded VectorY Therapeutics. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.